Regulation of calcific vascular and valvular disease by nuclear receptors. Issue 5 (October 2019)

• Record Type: Journal Article
• Authors: Sallam, Tamer; Tintut, Yin; Demer, Linda L.
• Is Part Of: Current opinion in lipidology. Volume 30:Issue 5(2019)
• Publication Date: 2019-10
• Subjects: atherosclerosis -- bone -- calcification -- lipoproteins -- vascular; Lipids -- Periodicals; 572.574
• DOI: 10.1097/MOL.0000000000000632
• Languages: English
• ISSNs: 1473-6535

Abstract

Abstract : Purpose of review: This review addresses recent developments in studies of lipid regulation of calcific disease of arteries and cardiac valves, including the role of nuclear receptors. The role of lipid-soluble signals and their receptors is timely given the recent evidence and concerns that lipid-lowering treatment may increase the rate of progression of coronary artery calcification, which has been long associated with increased cardiovascular risk. Understanding the mechanisms will be important for interpreting such clinical information. Recent findings: New findings support regulation of calcific vascular and valvular disease by nuclear receptors, including the vitamin D receptor, glucocorticoid receptor, nutrient-sensing nuclear receptors (liver X receptor, farnesoid X receptor, and peroxisome proliferator-activated receptors), and sex hormone (estrogen and androgen) receptors. There were two major unexpected findings: first, vitamin D supplementation, which was previously believed to prevent or reduce vascular calcification, showed no cardiovascular benefit in large randomized, controlled trials. Second, both epidemiological studies and coronary intravascular ultrasound studies suggest that treatment with HMG-CoA reductase inhibitors increases progression of coronary artery calcification, raising a question of whether there are mechanically stable and unstable forms of coronary calcification. Summary: For clinical practice and research, these new findings offer new fundamental mechanisms for vascular calcification and provide new cautionary insights for therapeutic avenues.